These findings were consistent with previous observations linking high levels of DLAT expression to poor prognosis in pancreatic cancer,42 clear cell renal cell carcinoma,43 hepatocellular carcinoma,8, 44 and NSCLC.45 This evidence concerns the gene DLAT and familial pancreatic carcinoma.